Answer
The selected product is licensed for adults with advanced renal cell carcinoma after previous sunitinib or cytokine treatment has failed.
Sources for this answer
- Axitinib 3mg Film-coated Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.